CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,641 enrolled
Drug / intervention
Nasopharyngeal swabother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00952367
NCT00952367N/ACompleted
CompareCT.gov

Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children Aged 12-18 Months in Six Cities of China

Wyeth is now a wholly owned subsidiary of Pfizer·observational·Posted Aug 6, 2009·Updated Apr 23, 2012

In Brief

An observational study evaluating Nasopharyngeal swab for Streptococcus Pneumoniae Infections. Completed, enrolled 3,641 participants across 6 sites.

Detailed Summary

This study is to observe the carriage rate of Streptococcus pneumoniae (S.p.), Haemophilus influenzae Type B (Hib) and Moraxella catarrhalis (M.Cat.) in healthy Chinese children aged 12-18 months in order to estimate the prevalence of pathogens that commonly cause infection in Chinese young children. The antibiotic resistance of all isolates and the serotypes distribution of S.p. isolates will also be tested. Potential risk factors for nasopharyngeal carriage will be collected.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStreptococcus Pneumoniae Infections
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 6, 2009
Enrollment StartApr 1, 2009
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.9 years ago

Interventions

Nasopharyngeal swabother

Nasopharyngeal swab